A.R.T. Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,080
| Closed | -$20K | – | 227 |
|
|
2020
Q2 | $20K | Buy |
+1,080
| New | +$20K | 0.03% | 258 |
|
|
2019
Q4 | – | Sell |
-11,758
| Closed | -$220K | – | 1653 |
|
|
2019
Q3 | $220K | Sell |
11,758
-4,710
| -29% | -$88.1K | 0.01% | 1160 |
|
|
2019
Q2 | $430K | Buy |
16,468
+8,030
| +95% | +$210K | 0.02% | 807 |
|
|
2019
Q1 | $217K | Sell |
8,438
-9,812
| -54% | -$252K | 0.01% | 1056 |
|
|
2018
Q4 | $420K | Buy |
18,250
+56
| +0.3% | +$1.29K | 0.03% | 797 |
|
|
2018
Q3 | $584K | Sell |
18,194
-24,542
| -57% | -$788K | 0.03% | 788 |
|
|
2018
Q2 | $1.21M | Buy |
42,736
+35,156
| +464% | +$995K | 0.05% | 550 |
|
|
2018
Q1 | $268K | Buy |
+7,580
| New | +$268K | 0.01% | 1172 |
|
|
2017
Q4 | – | Sell |
-1,550
| Closed | -$39K | – | 1619 |
|
|
2017
Q3 | $39K | Sell |
1,550
-1,760
| -53% | -$44.3K | ﹤0.01% | 1268 |
|
|
2017
Q2 | $90K | Buy |
+3,310
| New | +$90K | ﹤0.01% | 1264 |
|
|
2016
Q3 | – | Sell |
-6,015
| Closed | -$134K | – | 1077 |
|
|
2016
Q2 | $134K | Sell |
6,015
-5,663
| -48% | -$126K | 0.01% | 1164 |
|
|
2016
Q1 | $242K | Sell |
11,678
-840
| -7% | -$17.4K | 0.01% | 1113 |
|
|
2015
Q4 | $379K | Buy |
12,518
+2,840
| +29% | +$86K | 0.02% | 974 |
|
|
2015
Q3 | $239K | Sell |
9,678
-1,510
| -13% | -$37.3K | 0.01% | 1115 |
|
|
2015
Q2 | $360K | Buy |
+11,188
| New | +$360K | 0.01% | 1119 |
|
|
2015
Q1 | – | Sell |
-2,514
| Closed | -$57K | – | 1642 |
|
|
2014
Q4 | $57K | Buy |
2,514
+122
| +5% | +$2.77K | ﹤0.01% | 1338 |
|
|
2014
Q3 | $46K | Buy |
+2,392
| New | +$46K | ﹤0.01% | 1247 |
|
|
2014
Q1 | – | Sell |
-16,363
| Closed | -$466K | – | 1519 |
|
|
2013
Q4 | $466K | Buy |
16,363
+4,630
| +39% | +$132K | 0.02% | 793 |
|
|
2013
Q3 | $420K | Sell |
11,733
-10,139
| -46% | -$363K | 0.02% | 848 |
|
|
2013
Q2 | $730K | Buy |
+21,872
| New | +$730K | 0.02% | 741 |
|